Transcriptome analysis of primary adult B-cell lineage acute lymphoblastic leukemia identifies pathogenic variants and gene fusions, and predicts subtypes for in depth molecular diagnosis.
Saved in:
| Title: | Transcriptome analysis of primary adult B-cell lineage acute lymphoblastic leukemia identifies pathogenic variants and gene fusions, and predicts subtypes for in depth molecular diagnosis. |
|---|---|
| Authors: | Podgorica M; Department of Immunology, Oslo University Hospital, Oslo, Norway.; KG Jebsen Center for B-cell Malignancies, Institute of Clinical Medicine, Department of Immunology, University of Oslo, Oslo, Norway., Drivet E; Department of Immunology, Oslo University Hospital, Oslo, Norway.; KG Jebsen Center for B-cell Malignancies, Institute of Clinical Medicine, Department of Immunology, University of Oslo, Oslo, Norway., Viken JK; Department of Immunology, Oslo University Hospital, Oslo, Norway.; KG Jebsen Center for B-cell Malignancies, Institute of Clinical Medicine, Department of Immunology, University of Oslo, Oslo, Norway.; Department of Laboratory Medicine, University of California San Francisco, San Francisco, California, USA., Richman A; Department of Biomedical and Health Sciences, University of Vermont, Burlington, Vermont, USA., Vestbøstad J; Department of Immunology, Oslo University Hospital, Oslo, Norway.; KG Jebsen Center for B-cell Malignancies, Institute of Clinical Medicine, Department of Immunology, University of Oslo, Oslo, Norway., Szodoray P; B Cell Receptor Signaling Group (BCRSG), Department of Immunology, Oslo University Hospital, Oslo, Norway., Kvam AK; Department of Haematology, Oslo University Hospital, Oslo, Norway., Wik HS; Department of Haematology, Oslo University Hospital, Oslo, Norway., Tjønnfjord GE; KG Jebsen Center for B-cell Malignancies, Institute of Clinical Medicine, Department of Immunology, University of Oslo, Oslo, Norway.; Department of Haematology, Oslo University Hospital, Oslo, Norway., Munthe LA; Department of Immunology, Oslo University Hospital, Oslo, Norway.; KG Jebsen Center for B-cell Malignancies, Institute of Clinical Medicine, Department of Immunology, University of Oslo, Oslo, Norway., Frietze S; Department of Biomedical and Health Sciences, University of Vermont, Burlington, Vermont, USA., Schjerven H; Department of Immunology, Oslo University Hospital, Oslo, Norway.; KG Jebsen Center for B-cell Malignancies, Institute of Clinical Medicine, Department of Immunology, University of Oslo, Oslo, Norway.; Department of Laboratory Medicine, University of California San Francisco, San Francisco, California, USA.; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California, USA. |
| Source: | European journal of haematology [Eur J Haematol] 2024 May; Vol. 112 (5), pp. 731-742. Date of Electronic Publication: 2024 Jan 08. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Blackwell Country of Publication: England NLM ID: 8703985 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1600-0609 (Electronic) Linking ISSN: 09024441 NLM ISO Abbreviation: Eur J Haematol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1600-0609 |
|---|---|
| DOI: | 10.1111/ejh.14164 |
